Clinical trial

Tumor Treating Fields (TTF) in Combination with Stereotactic Radiosurgery(SRS) for Brain Metastases from Non-small Cell Lung Cancer.

NCT06716775

Study summary

ClinicalTrials.gov

Tumor Treating Fields (TTF) in Combination with Stereotactic Radiosurgery(SRS) for Brain Metastases from Non-small Cell Lung Cancer.

Design: INTERVENTIONAL · Status: NOT YET RECRUITING · Phase: NA

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

DEVICE · Unmapped registry intervention Tumor treating felds (TTF) Find medicine records · Find other trials using this name

OTHER · Unmapped registry intervention Best Standard of Care Find medicine records · Find other trials using this name

StatusNOT_YET_RECRUITING

Study typeINTERVENTIONAL

Start date2024-12-20

PhaseNA

Conditions

NSCLC Brain Metastasisunresolved

Interventions

Tumor treating felds (TTF)DEVICE

Best Standard of CareOTHER

Sponsors & collaborators

Jiangsu Healthy Life Innovation Medical Technology Co., Ltdlead sponsor

Shandong Cancer Hospital and Institutecollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06716775 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.